Clopidogrel is an anti-platelet agent, that is, a drug that inhibits the ability of platelets to clump together as part of a blood clot. The serum concentration of the active metabolites of ...

FDA-approved indications currently recommend that patients who undergo percutaneous intervention with drug-eluting stents (DESs) should be treated with clopidogrel for 3–6 months; however ...

Dr. Sabatine: Clopidogrel is a prodrug and it needs to be activated through sequential oxidative steps in the liver (Slide 1). There is another pathway where esterases can take that pro-drug and ...

Overall, prasugrel may be superior to the approved dose of the older drug, clopidogrel (Plavix), in many cases. But more doctors have been using an initial, higher-than-standard dose of ...

Find all the commercial and brand names of generic drug called Clopidogrel. This is an invaluable reference resource for healthcare professionals, patients, caregivers and anyone in need of ...

Prevalence of clopidogrel non-responders among patients with stable angina pectoris scheduled for elective coronary stent placement. Thromb. Haemost. 89 , 783–787 (2003).

"Triple therapy" with aspirin, clopidogrel, and warfarin has become an increasingly common clinical scenario in the drug-eluting stent era. While there is general acceptance that multiagent ...

MEDLINE e38. Lev EI, Patel RT, Maresh KJ, Guthikonda S, Granada J, DeLao T, Bray PF, Kleiman NS: Aspirin and clopidogrel drug response in patients undergoing percutaneous coronary intervention ...

MEDLINE e38. Lev EI, Patel RT, Maresh KJ, Guthikonda S, Granada J, DeLao T, Bray PF, Kleiman NS: Aspirin and clopidogrel drug response in patients undergoing percutaneous coronary intervention ...

Assessing over 18,000 patients in 43 countries, investigators reported that ticagrelor reduced deaths from vascular causes, heart attack, or stroke compared with clopidogrel (Plavix).